Nobel Award Honors Pioneering Body's Defenses Discoveries

The Nobel Prize in medical science was granted for revolutionary findings that clarify how the body's defense network targets harmful pathogens while sparing the healthy tissues.

A trio of renowned scientists—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this honor.

Their research identified specialized "security guards" within the immune system that eliminate malfunctioning defense cells capable of attacking the organism.

The discoveries are now enabling new treatments for immune disorders and malignancies.

These winners will share a monetary award worth 11 million SEK.

Decisive Findings

"Their work has been decisive for comprehending how the immune system functions and the reason we don't all suffer from serious autoimmune diseases," stated the head of the Nobel Committee.

This trio's studies address a core question: In what way does the defense system defend us from numerous invaders while leaving our healthy cells intact?

Our immune system employs immune cells that scan for indicators of infection, even pathogens and germs it has never encountered.

These cells employ detectors—known as receptors—that are produced by chance in a vast number of variations.

This gives the immune system the ability to fight a broad range of invaders, but the randomness of the process unavoidably creates immune cells that may attack the body.

Security Guards of the Immune System

Researchers previously knew that some of these problematic white blood cells were eliminated in the immune organ—where immune cells mature.

This year's award recognizes the identification of T-reg cells—known as the body's "peacekeepers"—which travel through the system to disarm other immune cells that assault the body's own tissues.

We know that this process fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

The Nobel panel stated, "These findings have laid the foundation for a new field of research and spurred the creation of new therapies, for example for cancer and autoimmune diseases."

In cancer, T-regs prevent the body from attacking the growth, so studies are focused on lowering their quantity.

For autoimmune diseases, trials are exploring increasing regulatory T-cells so the organism is no longer being harmed. A comparable approach could also be useful in reducing the risks of transplanted organ failure.

Pioneering Studies

Prof Sakaguchi, of Osaka University, performed tests on mice that had their thymus extracted, leading to self-attack conditions.

The researcher showed that injecting immune cells from healthy animals could prevent the illness—implying there was a mechanism for preventing defenders from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an inherited immune disorder in rodents and people that resulted in the identification of a gene critical for the way regulatory T-cells operate.

"The pioneering research has revealed how the immune system is kept in check by T-reg cells, stopping it from accidentally attacking the body's own tissues," commented a leading biological science specialist.

"The work is a remarkable example of how fundamental biological research can have broad implications for human health."